Suppr超能文献

一种用于复制缺陷型 E1 缺失型腺病毒增殖的新型互补细胞系。

A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.

机构信息

Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 672, Rochester, NY, 14642, USA.

出版信息

Cytotechnology. 2006 Jul;51(3):133-40. doi: 10.1007/s10616-006-9023-6. Epub 2006 Nov 18.

Abstract

Recombinant adenoviruses (Ad) are being explored as promising delivery systems for gene therapy and vaccination. However, there is a concern about the possibility of generating replication-competent adenoviruses (RCA) using the human embryonic kidney 293 cell line. We have constructed a new cell line named the UR cell line which can be used to produce Ad vectors free of RCA. This cell line is based on the human embryonic lung HEL 299 cell. We first constructed a shuttle plasmid which encodes the E1A/E1B sequence that is necessary for adenovirus replication. The shuttle plasmid was then transfected into HEL 299 cells. The presence of the E1A/E1B sequence and protein expression in the stably transformed UR cells was confirmed. Viruses produced in UR cells were still RCA-free after ten test passages, while adenovirus produced in 293 cells had generated RCA during the fourth passage. We conclude that the UR cell line is sufficiently stable, can effectively produce a virus yield comparable with 293 cells, and does not generate RCA formation during Ad propagation.

摘要

重组腺病毒(Ad)被探索作为基因治疗和疫苗接种的有前途的传递系统。然而,人们担心使用人胚肾 293 细胞系可能会产生复制能力的腺病毒(RCA)。我们构建了一种新的细胞系,命名为 UR 细胞系,可用于生产无 RCA 的 Ad 载体。该细胞系基于人胚肺 HEL 299 细胞。我们首先构建了一个穿梭质粒,其编码腺病毒复制所必需的 E1A/E1B 序列。然后将穿梭质粒转染到 HEL 299 细胞中。在稳定转化的 UR 细胞中证实了 E1A/E1B 序列的存在和蛋白表达。在 UR 细胞中产生的病毒在经过十次测试传代后仍然没有 RCA,而在 293 细胞中产生的腺病毒在第四代时已经产生了 RCA。我们得出结论,UR 细胞系足够稳定,能够有效地产生与 293 细胞相当的病毒产量,并且在 Ad 繁殖过程中不会产生 RCA 形成。

相似文献

1
A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.
Cytotechnology. 2006 Jul;51(3):133-40. doi: 10.1007/s10616-006-9023-6. Epub 2006 Nov 18.
3
Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture.
J Virol Methods. 2014 Nov;208:177-88. doi: 10.1016/j.jviromet.2014.08.013. Epub 2014 Aug 23.
4
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses.
BMC Biotechnol. 2024 Sep 27;24(1):67. doi: 10.1186/s12896-024-00894-x.
6
A recombinant E1-deleted porcine adenovirus-3 as an expression vector.
Virology. 2003 Sep 1;313(2):377-86. doi: 10.1016/s0042-6822(03)00286-1.

引用本文的文献

3
Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.
Clin Vaccine Immunol. 2012 Mar;19(3):359-64. doi: 10.1128/CVI.05384-11. Epub 2012 Jan 25.
4
Adenoviral producer cells.
Viruses. 2010 Aug;2(8):1681-1703. doi: 10.3390/v2081681. Epub 2010 Aug 16.
5
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.
Gene Ther. 2009 Mar;16(3):367-75. doi: 10.1038/gt.2008.181. Epub 2009 Jan 8.
6
Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.
Vaccine. 2007 Oct 23;25(43):7540-8. doi: 10.1016/j.vaccine.2007.08.035. Epub 2007 Sep 5.

本文引用的文献

1
N-fragment of edema factor as a candidate antigen for immunization against anthrax.
Vaccine. 2006 Jan 30;24(5):662-70. doi: 10.1016/j.vaccine.2005.08.056. Epub 2005 Aug 26.
2
Adenovirus-based genetic vaccines for biodefense.
Hum Gene Ther. 2005 Feb;16(2):157-68. doi: 10.1089/hum.2005.16.157.
3
Biology of adenovirus and its use as a vector for gene therapy.
Hum Gene Ther. 2004 Nov;15(11):1022-33. doi: 10.1089/hum.2004.15.1022.
4
Plaque assay for avian metapneumovirus using a Japanese quail fibrosarcoma cell line (QT-35).
J Virol Methods. 2003 Jan;107(1):9-14. doi: 10.1016/s0166-0934(02)00207-0.
5
Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.
J Virol. 2001 Dec;75(23):11474-82. doi: 10.1128/JVI.75.23.11474-11482.2001.
6
8
Characterization and quality control of recombinant adenovirus vectors for gene therapy.
J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):263-80. doi: 10.1016/s0378-4347(00)00557-0.
9
Guidance for human somatic cell therapy and gene therapy.
Hum Gene Ther. 2001 Feb 10;12(3):303-14. doi: 10.1089/10430340150218431.
10
Production of first generation adenovirus vectors: a review.
Gene Ther. 2000 Oct;7(20):1707-14. doi: 10.1038/sj.gt.3301301.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验